0 Ratings
ID

24713

Description

Microvascular Coronary Disease In Women: Impact Of Ranolazine; ODM derived from: https://clinicaltrials.gov/show/NCT00570089

Link

https://clinicaltrials.gov/show/NCT00570089

Keywords

Versions (1)
  1. 8/14/17 8/14/17 -
Uploaded on

August 14, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Myocardial Ischemia NCT00570089

    English

    Eligibility Myocardial Ischemia NCT00570089

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    1. women with signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing) in the absence of obstructive coronary artery disease (epicardial coronary stenosis <50% luminal diameter stenosis).
    Description

    Gender | Signs and Symptoms Myocardial Ischemia | Chest Pain | Cardiac stress test abnormal | Testing Noninvasive Abnormal | Coronary Artery Disease Obstructive Absent | Coronary Stenosis Epicardial | Percent Diameter Stenosis Measurement Luminal

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2,1]
    C0037088
    UMLS CUI [2,2]
    C0151744
    UMLS CUI [3]
    C0008031
    UMLS CUI [4]
    C1096350
    UMLS CUI [5,1]
    C0039593
    UMLS CUI [5,2]
    C2986496
    UMLS CUI [5,3]
    C0205161
    UMLS CUI [6,1]
    C1956346
    UMLS CUI [6,2]
    C0549186
    UMLS CUI [6,3]
    C0332197
    UMLS CUI [7,1]
    C0242231
    UMLS CUI [7,2]
    C0442016
    UMLS CUI [8,1]
    C3897965
    UMLS CUI [8,2]
    C0524462
    2. women with ≥10% myocardial ischemia by cmr perfusion.
    Description

    Gender | Myocardial Ischemia Percentage | Cardiovascular magnetic resonance imaging Perfusion

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2,1]
    C0151744
    UMLS CUI [2,2]
    C0439165
    UMLS CUI [3,1]
    C3873775
    UMLS CUI [3,2]
    C0428857
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    1. contraindications to withholding nitrates, beta-blockers, calcium channel agents, ace/arb agents for 48 hours prior to testing.
    Description

    Medical contraindication Nitrates | Medical contraindication Adrenergic beta-Antagonists | Medical contraindication Calcium Channel Blockers | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin II receptor antagonist

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1301624
    UMLS CUI [1,2]
    C0028125
    UMLS CUI [2,1]
    C1301624
    UMLS CUI [2,2]
    C0001645
    UMLS CUI [3,1]
    C1301624
    UMLS CUI [3,2]
    C0006684
    UMLS CUI [4,1]
    C1301624
    UMLS CUI [4,2]
    C0003015
    UMLS CUI [5,1]
    C1301624
    UMLS CUI [5,2]
    C0521942
    2. contraindications in cmr including aicd, pacemaker, untreatable claustrophobia or known angio-edema.
    Description

    Medical contraindication Cardiovascular magnetic resonance imaging | Automatic Implantable Cardioverter-Defibrillators | Artificial cardiac pacemaker | Claustrophobia Treating Unsuccessful | Angioedema

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1301624
    UMLS CUI [1,2]
    C3873775
    UMLS CUI [2]
    C0972395
    UMLS CUI [3]
    C0030163
    UMLS CUI [4,1]
    C0008909
    UMLS CUI [4,2]
    C1522326
    UMLS CUI [4,3]
    C1272705
    UMLS CUI [5]
    C0002994
    3. contraindications to ranolazine including hepatic insufficiency, prolonged qt, renal failure.
    Description

    Medical contraindication ranolazine | Hepatic Insufficiency | Prolonged QT interval | Kidney Failure

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1301624
    UMLS CUI [1,2]
    C0073633
    UMLS CUI [2]
    C1306571
    UMLS CUI [3]
    C0151878
    UMLS CUI [4]
    C0035078
    4. women taking drugs that inhibit cyp3a such as diltiazem, verapamil, ketoconazole, macrolides or hiv protease inhibitors.
    Description

    Gender | CYP3A Inhibitors | Diltiazem | Verapamil | Ketoconazole | Macrolides | HIV Protease Inhibitors

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C3850056
    UMLS CUI [3]
    C0012373
    UMLS CUI [4]
    C0042523
    UMLS CUI [5]
    C0022625
    UMLS CUI [6]
    C0282563
    UMLS CUI [7]
    C0162714
    5. women less than 18 years of age.
    Description

    Gender | Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2]
    C0001779
    6. women on drugs that prolong the qt interval such as class ia or iii antiarrhythmic agents, erythromycin, certain antipsychotics.
    Description

    Gender | Pharmaceutical Preparations Causing Prolonged QT interval | Anti-Arrhythmia Agents Class | Erythromycin | Antipsychotic Agents

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2,1]
    C0013227
    UMLS CUI [2,2]
    C0678227
    UMLS CUI [2,3]
    C0151878
    UMLS CUI [3,1]
    C0003195
    UMLS CUI [3,2]
    C0456387
    UMLS CUI [4]
    C0014806
    UMLS CUI [5]
    C0040615
    7. pregnancy or breast feeding.
    Description

    Pregnancy | Breast Feeding

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    8. life expectancy less than 6 months.
    Description

    Life Expectancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    Back to the top of the page

    Similar models

    Eligibility Myocardial Ischemia NCT00570089

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Gender | Signs and Symptoms Myocardial Ischemia | Chest Pain | Cardiac stress test abnormal | Testing Noninvasive Abnormal | Coronary Artery Disease Obstructive Absent | Coronary Stenosis Epicardial | Percent Diameter Stenosis Measurement Luminal
    Item
    1. women with signs and symptoms of myocardial ischemia (chest pain, abnormal stress testing, abnormal noninvasive testing) in the absence of obstructive coronary artery disease (epicardial coronary stenosis <50% luminal diameter stenosis).
    boolean
    C0079399 (UMLS CUI [1])
    C0037088 (UMLS CUI [2,1])
    C0151744 (UMLS CUI [2,2])
    C0008031 (UMLS CUI [3])
    C1096350 (UMLS CUI [4])
    C0039593 (UMLS CUI [5,1])
    C2986496 (UMLS CUI [5,2])
    C0205161 (UMLS CUI [5,3])
    C1956346 (UMLS CUI [6,1])
    C0549186 (UMLS CUI [6,2])
    C0332197 (UMLS CUI [6,3])
    C0242231 (UMLS CUI [7,1])
    C0442016 (UMLS CUI [7,2])
    C3897965 (UMLS CUI [8,1])
    C0524462 (UMLS CUI [8,2])
    Gender | Myocardial Ischemia Percentage | Cardiovascular magnetic resonance imaging Perfusion
    Item
    2. women with ≥10% myocardial ischemia by cmr perfusion.
    boolean
    C0079399 (UMLS CUI [1])
    C0151744 (UMLS CUI [2,1])
    C0439165 (UMLS CUI [2,2])
    C3873775 (UMLS CUI [3,1])
    C0428857 (UMLS CUI [3,2])
    Item Group
    C0680251 (UMLS CUI)
    Medical contraindication Nitrates | Medical contraindication Adrenergic beta-Antagonists | Medical contraindication Calcium Channel Blockers | Medical contraindication Angiotensin-Converting Enzyme Inhibitors | Medical contraindication Angiotensin II receptor antagonist
    Item
    1. contraindications to withholding nitrates, beta-blockers, calcium channel agents, ace/arb agents for 48 hours prior to testing.
    boolean
    C1301624 (UMLS CUI [1,1])
    C0028125 (UMLS CUI [1,2])
    C1301624 (UMLS CUI [2,1])
    C0001645 (UMLS CUI [2,2])
    C1301624 (UMLS CUI [3,1])
    C0006684 (UMLS CUI [3,2])
    C1301624 (UMLS CUI [4,1])
    C0003015 (UMLS CUI [4,2])
    C1301624 (UMLS CUI [5,1])
    C0521942 (UMLS CUI [5,2])
    Medical contraindication Cardiovascular magnetic resonance imaging | Automatic Implantable Cardioverter-Defibrillators | Artificial cardiac pacemaker | Claustrophobia Treating Unsuccessful | Angioedema
    Item
    2. contraindications in cmr including aicd, pacemaker, untreatable claustrophobia or known angio-edema.
    boolean
    C1301624 (UMLS CUI [1,1])
    C3873775 (UMLS CUI [1,2])
    C0972395 (UMLS CUI [2])
    C0030163 (UMLS CUI [3])
    C0008909 (UMLS CUI [4,1])
    C1522326 (UMLS CUI [4,2])
    C1272705 (UMLS CUI [4,3])
    C0002994 (UMLS CUI [5])
    Medical contraindication ranolazine | Hepatic Insufficiency | Prolonged QT interval | Kidney Failure
    Item
    3. contraindications to ranolazine including hepatic insufficiency, prolonged qt, renal failure.
    boolean
    C1301624 (UMLS CUI [1,1])
    C0073633 (UMLS CUI [1,2])
    C1306571 (UMLS CUI [2])
    C0151878 (UMLS CUI [3])
    C0035078 (UMLS CUI [4])
    Gender | CYP3A Inhibitors | Diltiazem | Verapamil | Ketoconazole | Macrolides | HIV Protease Inhibitors
    Item
    4. women taking drugs that inhibit cyp3a such as diltiazem, verapamil, ketoconazole, macrolides or hiv protease inhibitors.
    boolean
    C0079399 (UMLS CUI [1])
    C3850056 (UMLS CUI [2])
    C0012373 (UMLS CUI [3])
    C0042523 (UMLS CUI [4])
    C0022625 (UMLS CUI [5])
    C0282563 (UMLS CUI [6])
    C0162714 (UMLS CUI [7])
    Gender | Age
    Item
    5. women less than 18 years of age.
    boolean
    C0079399 (UMLS CUI [1])
    C0001779 (UMLS CUI [2])
    Gender | Pharmaceutical Preparations Causing Prolonged QT interval | Anti-Arrhythmia Agents Class | Erythromycin | Antipsychotic Agents
    Item
    6. women on drugs that prolong the qt interval such as class ia or iii antiarrhythmic agents, erythromycin, certain antipsychotics.
    boolean
    C0079399 (UMLS CUI [1])
    C0013227 (UMLS CUI [2,1])
    C0678227 (UMLS CUI [2,2])
    C0151878 (UMLS CUI [2,3])
    C0003195 (UMLS CUI [3,1])
    C0456387 (UMLS CUI [3,2])
    C0014806 (UMLS CUI [4])
    C0040615 (UMLS CUI [5])
    Pregnancy | Breast Feeding
    Item
    7. pregnancy or breast feeding.
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Life Expectancy
    Item
    8. life expectancy less than 6 months.
    boolean
    C0023671 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial